Capricor Therapeutics Shares Rise After Upgrade From B. Riley
MT newswire2026/09/14 19:07Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
03:07 PM EDT, 09/14/2026 (MT Newswires) -- Capricor Therapeutics' (CAPR) shares were up more than 4% in Monday trading after B. Riley upgraded the biotechnology company's stock to buy from neutral, and raised its price target to $21 from $5. Trading volume stood at over 2 million shares, compared with a daily average of roughly 6.4 million. Price: 8.73, Change: +0.36, Percent Change: +4.30
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Sector Update: Energy
MT newswire•2026/09/14 19:45
Residential Building Permits Drop, Sparking Inventory Shortage Concerns Amid Affordability Woes, Zillow Says
MT newswire•2026/09/14 19:43
UK regulators to develop tokenization roadmap after industry feedback
Cointelegraph•2026/09/14 19:42
Cybersecurity Names Trading at Premiums After Monday's Rally -- Market Talk
Dow Jones•2026/09/14 19:42
